Actively Recruiting
Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-09-03
50
Participants Needed
1
Research Sites
362 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the study aims to collect tumor tissue at the moment of progression under Immune checkpoint inhibitors (ICI) in biological resources center in Ambroise Paré hospital, in order to insure later study on molecular mechanism involving the progression of NSCLC and SCLC under ICI. The further analysis of research will be performed in the EA 4340 unity, Biomarkers and Clinical Trials in cancerology and onco-hematology, UVSQ, University of Paris-Saclay.
CONDITIONS
Official Title
Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC)
- Previously treated with immune checkpoint inhibitors (ICI) and experienced progression during ICI treatment
- Provided written informed consent for the study
- 18 years of age or older on the day of signing informed consent
You will not qualify if you...
- Under legal guardianship or curatorship
- Unable to provide written informed consent for the study
- Technical inability to perform tissue rebiopsy under local anesthesia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service de Pneumologie et Oncologie thoracique, Hôpital Ambroise Paré, APHP
Boulogne-Billancourt, France, 92100
Actively Recruiting
Research Team
E
Etienne Giroux Leprieur, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here